NS Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5M Sell
358,580
-676
-0.2% -$54.1K 1.01% 37
2025
Q4
$34.3M Buy
359,256
+890
+0.2% +$87.3K 1.34% 22
2025
Q3
$35M Sell
358,366
-285
-0.1% -$29.5K 1.35% 19
2025
Q2
$38.5M Sell
358,651
-9,538
-3% -$965K 1.57% 18
2025
Q1
$37.1M Buy
368,189
+5,704
+2% +$574K 1.63% 19
2024
Q4
$32.4M Sell
362,485
-6,046
-2% -$532K 1.34% 24
2024
Q3
$30.9M Buy
368,531
+8,980
+2% +$708K 1.3% 26
2024
Q2
$27.7M Buy
359,551
+1,669
+0.5% +$122K 1.26% 27
2024
Q1
$24.5M Buy
357,882
+2,005
+0.6% +$129K 1.13% 32
2023
Q4
$20.6M Buy
355,877
+1,699
+0.5% +$90.7K 1% 40
2023
Q3
$18.7M Sell
354,178
-3,804
-1% -$200K 1.01% 40
2023
Q2
$19.4M Sell
357,982
-2,644
-0.7% -$138K 1.02% 43
2023
Q1
$18M Buy
360,626
+266
+0.1% +$12.5K 1.01% 47
2022
Q4
$16.7M Buy
360,360
+1,489
+0.4% +$64.5K 1.01% 48
2022
Q3
$13.9M Buy
358,871
+14,161
+4% +$568K 0.9% 49
2022
Q2
$12.8M Buy
344,710
+3,483
+1% +$142K 0.78% 51
2022
Q1
$15.1M Sell
341,227
-11,208
-3% -$486K 0.81% 48
2021
Q4
$15M Buy
352,435
+202
+0.1% +$8.49K 0.7% 51
2021
Q3
$15.3M Buy
352,233
+807
+0.2% +$35.7K 0.78% 53
2021
Q2
$15M Sell
351,426
-21,709
-6% -$913K 0.79% 49
2021
Q1
$14.4M Sell
373,135
-355
-0.1% -$13.4K 0.84% 48
2020
Q4
$13.4M Buy
373,490
+8,893
+2% +$321K 0.78% 51
2020
Q3
$13.9M Buy
364,597
+18,364
+5% +$708K 0.92% 45
2020
Q2
$12.2M Buy
346,233
+1,142
+0.3% +$41.1K 0.9% 47
2020
Q1
$11.3M Buy
+345,091
New +$13.5M 1.05% 39

Other funds holding BSX